Nicotine: abused substance and therapeutic agent.
Identifieur interne : 001F13 ( Ncbi/Checkpoint ); précédent : 001F12; suivant : 001F14Nicotine: abused substance and therapeutic agent.
Auteurs : J. Le HouezecSource :
- Journal of Psychiatry and Neuroscience [ 1180-4882 ] ; 1998.
Abstract
Tobacco dependence is a complex phenomenon that is not fully understood. Nicotine is the main alkaloid in tobacco and the addictive compound of tobacco. It can improve both mood and cognitive functioning; these positive effects are strong reinforcements for smokers and contribute to their addiction. Opposite results also have been reported, however, and the effects of nicotine remain controversial. Recent epidemiological and empirical studies have indicated that smoking or nicotine or both may have protective effects against certain diseases. These findings have suggested that nicotine may be used as a therapeutic agent. However, because a variety of nicotinic cholinergic receptors are present in the brain, new agonist compounds may prove to be more effective than nicotine for therapeutic purposes. Studies are reviewed and the suggestion made that nicotine may prove useful as a tool to help us understand normal and pathological brain functioning.
Url:
PubMed: 9549250
PubMed Central: 1188908
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000301
- to stream Pmc, to step Curation: 000299
- to stream Pmc, to step Checkpoint: 000951
- to stream Ncbi, to step Merge: 001F13
- to stream Ncbi, to step Curation: 001F13
Links to Exploration step
PMC:1188908Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Nicotine: abused substance and therapeutic agent.</title><author><name sortKey="Le Houezec, J" sort="Le Houezec, J" uniqKey="Le Houezec J" first="J" last="Le Houezec">J. Le Houezec</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">9549250</idno><idno type="pmc">1188908</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188908</idno><idno type="RBID">PMC:1188908</idno><date when="1998">1998</date><idno type="wicri:Area/Pmc/Corpus">000301</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000301</idno><idno type="wicri:Area/Pmc/Curation">000299</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000299</idno><idno type="wicri:Area/Pmc/Checkpoint">000951</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000951</idno><idno type="wicri:Area/Ncbi/Merge">001F13</idno><idno type="wicri:Area/Ncbi/Curation">001F13</idno><idno type="wicri:Area/Ncbi/Checkpoint">001F13</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Nicotine: abused substance and therapeutic agent.</title><author><name sortKey="Le Houezec, J" sort="Le Houezec, J" uniqKey="Le Houezec J" first="J" last="Le Houezec">J. Le Houezec</name></author></analytic><series><title level="j">Journal of Psychiatry and Neuroscience</title><idno type="ISSN">1180-4882</idno><idno type="eISSN">1488-2434</idno><imprint><date when="1998">1998</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Tobacco dependence is a complex phenomenon that is not fully understood. Nicotine is the main alkaloid in tobacco and the addictive compound of tobacco. It can improve both mood and cognitive functioning; these positive effects are strong reinforcements for smokers and contribute to their addiction. Opposite results also have been reported, however, and the effects of nicotine remain controversial. Recent epidemiological and empirical studies have indicated that smoking or nicotine or both may have protective effects against certain diseases. These findings have suggested that nicotine may be used as a therapeutic agent. However, because a variety of nicotinic cholinergic receptors are present in the brain, new agonist compounds may prove to be more effective than nicotine for therapeutic purposes. Studies are reviewed and the suggestion made that nicotine may prove useful as a tool to help us understand normal and pathological brain functioning.</p></div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Le Houezec, J" sort="Le Houezec, J" uniqKey="Le Houezec J" first="J" last="Le Houezec">J. Le Houezec</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F13 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 001F13 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= PMC:1188908
|texte= Nicotine: abused substance and therapeutic agent.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:9549250" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |